e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Systemic and airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Myeloperoxidase of bronchial leucocytes as a biomarker of osmotic bronchial hyperresponsiveness in asthmatics
Juliy Perelman (Blagoveshchensk, Amur Oblast, Russian Federation), Juliy M. Perelman, Aleksey B. Pirogov, Anna G. Prikhodko, Sergey V. Zinoviev, Victor P. Kolosov, Tatiana A. Maltseva
Source:
International Congress 2015 – Systemic and airway biomarkers
Session:
Systemic and airway biomarkers
Session type:
Thematic Poster Session
Number:
3872
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Juliy Perelman (Blagoveshchensk, Amur Oblast, Russian Federation), Juliy M. Perelman, Aleksey B. Pirogov, Anna G. Prikhodko, Sergey V. Zinoviev, Victor P. Kolosov, Tatiana A. Maltseva. Myeloperoxidase of bronchial leucocytes as a biomarker of osmotic bronchial hyperresponsiveness in asthmatics. Eur Respir J 2015; 46: Suppl. 59, 3872
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Cell composition of induced sputum in patients with uncontrolled asthma and its participation in the formation of cold airway hyperresponsiveness
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Source: Eur Respir J 2012; 40: 1098-1105
Year: 2012
Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014
Signs of oxidative stress in bronchial asthma
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Oxidative stress and biomarkers in patients with bronchial asthma
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
The combination of elevated FeNO and blood eosinophils relate to reduced lung function and increased bronchial responsiveness in young asthmatics
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Neutrophils in bronchial mucosa, sputum and blood after administration of the CXCR2-antagonist AZD5069 - An explorative study in neutrophilic asthma
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Clinical-functional features of osmotic airway hyperresponsiveness in patients with asthma
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Asthma
Source: Respipedia Article
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept